#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer stage IV

Recruiting

Registered drugNo placebo

Study on Maintenance Treatment with Pembrolizumab and Pemetrexed for Stage IV Non-Small Cell Lung Cancer Patients After Initial Chemotherapy and Immunotherapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Acute lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Blinatumomab, Ponatinib, and Isatuximab for Adults Aged 18-65 with Newly Diagnosed Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Not yet recruiting

Registered drug

Efficacy of dapagliflozin in adult patients with septic shock and microcirculatory dysfunction

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Dapagliflozin

Contact Research Centre

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Not yet recruiting

Registered drugNo placebo

Study of nemtabrutinib combined with venetoclax and obinutuzumab in untreated CLL/SLL patients with TP53 alterations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Nemtabrutinib

Contact Research Centre

T-cell type acute leukaemia

Not yet recruiting

Registered drugNo placebo

Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Infertility male

Not yet recruiting

Investigational

Study evaluating the effect of isotretinoin on sperm production in men with low sperm count

Investigational

France

Participants:18–64 years
Substances:Isotretinoin

Contact Research Centre

Chronic lymphocytic leukaemia

Not yet recruiting

Registered drugNo placebo

Study of pirtobrutinib combined with immuno-chemotherapy for previously untreated patients with symptomatic chronic lymphocytic leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Registered drug

Study of zipalertinib plus chemotherapy versus placebo plus chemotherapy in patients with stage IB-IIIA non-small cell lung cancer with uncommon EGFR mutations after surgery

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Plasma cell myeloma

Not yet recruiting

Registered drugNo placebo

Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

Registered drugNo placebo

France

Participants:18–64 years
Substances:Carfilzomib

Contact Research Centre

Sjogren's syndrome

Not recruiting

Investigational

Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

France

Participants:18–64 years · 65+ years
Substances:Dazodalibep

Contact Research Centre

Sjogren's syndrome

Not recruiting

Investigational

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

France

Participants:18–64 years · 65+ years
Substances:Dazodalibep

Contact Research Centre

Neurodermatitis

Not recruiting

Investigational

Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

Investigational

France

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.